Around the globe we have been keenly watching and waiting for the development, production, and delivery of vaccines. Now that vaccines are here, this bulletin looks at the regulatory process, medical guidelines, and the delivery approach.
Where local guidelines fall outside of those stipulated by the manufacturer, there is a potential threat to vaccine effectiveness as well as a possibly increased chance that novel and significant mutational strains appear. The difficult challenge of vaccine hesitancy and real-world effectiveness is also discussed.